Adverse events148

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 148

Type	Event	Organ system	Group	Affected	At risk
other	pyrexia	General disorders	ZD6474 (Gemcitabine), Vandetanib	17	61
other	pyrexia	General disorders	Placebo to Match ZD6474 (Gemcitabine), Vandetanib	17	63
other	Fatigue	General disorders	ZD6474 (Gemcitabine), Vandetanib	14	61
other	Fatigue	General disorders	Placebo to Match ZD6474 (Gemcitabine), Vandetanib	15	63
other	Asthenia	General disorders	ZD6474 (Gemcitabine), Vandetanib	9	61
other	Asthenia	General disorders	Placebo to Match ZD6474 (Gemcitabine), Vandetanib	13	63
other	Dispnoea	Respiratory, thoracic and mediastinal disorders	ZD6474 (Gemcitabine), Vandetanib	13	61
other	Dispnoea	Respiratory, thoracic and mediastinal disorders	Placebo to Match ZD6474 (Gemcitabine), Vandetanib	19	63
other	Cough	Respiratory, thoracic and mediastinal disorders	ZD6474 (Gemcitabine), Vandetanib	9	61
other	Cough	Respiratory, thoracic and mediastinal disorders	Placebo to Match ZD6474 (Gemcitabine), Vandetanib	10	63
other	PLT count decrease	Blood and lymphatic system disorders	ZD6474 (Gemcitabine), Vandetanib	7	61
other	PLT count decrease	Blood and lymphatic system disorders	Placebo to Match ZD6474 (Gemcitabine), Vandetanib	9	63
other	Neutropenia	Blood and lymphatic system disorders	ZD6474 (Gemcitabine), Vandetanib	12	61
other	Neutropenia	Blood and lymphatic system disorders	Placebo to Match ZD6474 (Gemcitabine), Vandetanib	12	63
other	Anaemia	Blood and lymphatic system disorders	ZD6474 (Gemcitabine), Vandetanib	8	61
other	Anaemia	Blood and lymphatic system disorders	Placebo to Match ZD6474 (Gemcitabine), Vandetanib	14	63
other	Thrombocytopenia	Blood and lymphatic system disorders	ZD6474 (Gemcitabine), Vandetanib	7	61
other	Thrombocytopenia	Blood and lymphatic system disorders	Placebo to Match ZD6474 (Gemcitabine), Vandetanib	4	63
other	Diarrhoea	Gastrointestinal disorders	ZD6474 (Gemcitabine), Vandetanib	9	61
other	Diarrhoea	Gastrointestinal disorders	Placebo to Match ZD6474 (Gemcitabine), Vandetanib	9	63

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00753714/events

API reference For AI assistants

Adverse events148

Sources 3

Read this list from software.